DFnet CEO Amy Apostoleris Recognized Among Top 100 Innovators & Entrepreneurs
DFnet is proud to congratulate our CEO, Amy Apostoleris, on being named to the Top 100 Innovators & Entrepreneurs list, a global recognition honoring leaders who are driving meaningful innovation and impact across industries.
With more than 30 years of experience spanning pharmaceutical, biotech, MedTech, and clinical research, Amy is widely respected for her ability to scale organizations, lead digital transformation, and align commercial success with public health priorities. Her career has included executive and leadership roles across industry and academia, as well as the successful growth of organizations from early-stage operations to global enterprises.
As CEO of DFnet, Amy leads the company’s strategic vision, partnerships, and long-term growth, building on DFnet’s strong foundation in eClinical software, clinical data management, and biostatistics services. Under her leadership, DFnet continues to expand its support for biopharmaceutical and medical device research while remaining deeply committed to public health and research in underserved regions.
At DFnet, Amy’s leadership is grounded in a clear purpose. She is deeply committed to staying close to the patient and using data to drive breakthroughs that matter. That commitment is reflected in how DFnet partners with sponsors and research teams, bringing rigor, innovation, and operational excellence to studies designed to improve outcomes for patients worldwide. This recognition reflects not only Amy’s professional accomplishments, but also her commitment to science-driven leadership and the people behind every study, including patients, sponsors, and research teams.
On behalf of the entire DFnet team, congratulations to Amy on this well-deserved honor.
To stay connected with Amy and follow her perspective on leadership, innovation, and patient-focused research, connect with her on LinkedIn.
